Mirati Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

SEC filing history

Showing 501-525 of 798 matching filings.

Per page
25
Current page
21
4

PRIMARY DOCUMENT

Filing date
18 Jan 2018
Reporting date
16 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
11 Jan 2018
Reporting date
07 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Nov 2017
Reporting date
21 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
22 Nov 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87670

AMENDMENT NO. 4

Filing date
20 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87670

SC 13D/A

Filing date
20 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A filing

Filing date
20 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207848

424B5

Filing date
16 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

FORM 8-K

Filing date
16 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MIRATI THERAPEUTICS, INC.

Filing date
16 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207848

424B5

Filing date
15 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
13 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
01 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
03 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
03 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .